Related Experiment Videos
Naltrexone maintenance treatment for opioid dependence
U Kirchmayer1, M Davoli, A Verster
1Osservatorio Epidemiologico della Regione Lazio, Via di S. Costanza, 53, Rome, Lazio, Italy, 00198. oss.epid.reg.lazio@agora.stm.it
The Cochrane Database of Systematic Reviews
|May 5, 2000
Summary
Naltrexone maintenance treatment shows a trend towards preventing relapse in opioid addicts. However, current research quality is insufficient for a definitive evaluation, necessitating further rigorous clinical trials.
Area of Science:
- Pharmacology and Addiction Medicine
- Clinical Trial Methodology
- Evidence-Based Medicine
Background:
- Naltrexone maintenance therapy has been widely used for over a decade for opioid addiction treatment.
- Despite its prevalence, comprehensive research documentation and evaluation of its efficacy remain limited.
Purpose of the Study:
- To systematically evaluate the effectiveness of naltrexone maintenance treatment in preventing relapse among individuals recovering from opioid addiction post-detoxification.
Main Methods:
- A systematic literature search was conducted across multiple databases (MEDLINE, EMBASE, CCTR) and other sources up to June 1998.
- Eleven studies, varying in methodological quality and randomization, were included and analyzed.
- Data extraction and analysis considered study quality, adherence, and intervention success, with limited meta-analysis performed due to heterogeneity.
Main Results:
- The review included eleven studies, with significant heterogeneity and low methodological quality observed.
- Meta-analysis was limited, yielding statistically weak quantitative results.
- A discernible trend favoring naltrexone maintenance was noted for specific patient subgroups.
Conclusions:
- Existing clinical trials are insufficient for a conclusive assessment of naltrexone maintenance treatment efficacy.
- Further high-quality clinical trials are urgently required to establish robust evidence for naltrexone's role in opioid addiction relapse prevention.